Contraction in all muscles results from the relative sliding of thick and thin filaments. The process is driven by the myosin-crossbridge motors projecting from thick filaments and interacting cyclically with actin subunits on the thin filament molecular track. In skeletal and cardiac muscles, contraction is switched on and off by changes in sarcoplasmic free Ca
2+ concentration and by the corresponding binding and dissociation of Ca
2+ from the troponin complex, located on thin filaments. Crossbridge dynamics is a function of the myosin ATPase, which itself is activated by myosin-crossbridge binding to actin. Thus, any modulation of actin-activation would, in turn, serve to regulate contraction. Indeed, at low Ca
2+, actin-myosin interaction is inhibited because myosin binding sites on actin become inaccessible. It is generally recognized that this inhibition occurs when Ca
2+-free troponin impinges on elongated tropomyosin to then block myosin binding (reviewed in
1,2). In contrast, the involvement of troponin in muscle activation is less well characterized. The crossbridge cycle may turn on simply because the troponin constraint is released at high Ca
2+ and tropomyosin defaults to an unstrained, non-blocking position on actin. Alternatively, Ca
2+-saturated troponin may play a more dynamic role and facilitate regulatory switching by actively promoting tropomyosin movement away from the blocking position. We have investigated these possibilities using electron microscopy and 3D reconstruction of thin filaments, and report here on troponin’s structural influence over tropomyosin at high Ca
2+.
Tropomyosin is a ~40 nm long “coiled-coil” α-helical protein, which lies along the long-pitch double helical array of actin monomers on thin filaments
3–5. Tropomyosin molecules associate together in an end-to-end fashion
6 to form a continuous strand, with each tropomyosin spanning 7 successive actin molecules. This arrangement is possible because tropomyosin possesses a series of 7 quasi-repeating motifs designed to bind to neighboring actin monomers along filaments
7–9. In turn, troponin, consisting of 3 subunits (TnT, TnI, and TnC), binds to tropomyosin at specific points along the tropomyosin molecule
10–13; troponin complexes therefore assume the 40 nm periodicity of tropomyosin on thin filaments. Troponin is thought to have multiple, compartmentalized functions, with each subunit having a particular role in binding tropomyosin or Ca
2+ or in inhibiting actomyosin ATPase
14. TnC is well characterized and functions as the Ca
2+ receptor. After binding Ca
2+, it neutralizes the inhibition of actomyosin ATPase imposed by TnI (the inhibitory subunit). TnT, a fairly long asymmetric molecule
15 (~19 nm), links the entire troponin complex to tropomyosin
14,16,17. The N-terminal “tail” of TnT binds alongside tropomyosin on thin filaments, bridging the head-to-tail joint between adjacent tropomyosin molecules. However, the C-terminal part of TnT converges on TnC and TnI and interacts with them to form the core domain of troponin
18,19. Other than providing a scaffold for TnI and TnC, its actions near or within the core domain are obscure. The view of TnT solely as a structural intermediary between troponin subunits and tropomyosin may be an oversimplification. In this regard, biochemical approaches have shown that in concert with tropomyosin and the rest of the troponin complex, TnT enhances actomyosin ATPase at high Ca
2+(
2,20,21), suggesting that it and the troponin core domain play more than just a permissive role during activation. Thus, troponin subunits may have a dual role in thin filament regulation, with TnI being linked to inhibition at low Ca
2+ and TnT and the rest of the complex linked to activation at high Ca
2+(
22).
In the complete absence of other factors, tropomyosin is thought to be able to oscillate laterally over a narrow region of the flat surface of actin
23–28. It is generally assumed, although not explicitly established, that this intrinsic ability to shift azimuthally around actin filaments at low energy cost is inherent to and necessary for the thin filament regulatory mechanism
23–25. Presumably, tropomyosin location becomes biased towards specific regulatory positions on actin
25,29 in the presence of troponin and/or myosin, and depending on levels of Ca
2+ binding to troponin and myosin binding to actin. At low Ca
2+, tropomyosin localizes over the outer domain of actin (on actin subdomains 1 and 2, covering myosin binding sites; the B-state position). At high Ca
2+, tropomyosin moves to actin’s inner domain (to the edge of subdomains 3 and 4, exposing most but not all of the myosin binding site; the C-state position), and after myosin binding it moves further onto the inner domain (exposing the entire myosin binding site; the M-state position)
29. Thus the Ca
2+-induced movement of tropomyosin is thought to increase the probability of myosin binding, and the resulting myosin interaction leads to a further tropomyosin shift and full activation of the thin filament
29.
We recently showed that the C-terminal end of TnI (cTerm-TnI) drives tropomyosin to the B-state blocking position on the actin outer domain at low Ca
2+(
30,31). Here we have extended these studies to characterize how troponin influences tropomyosin in the presence of Ca
2+. Our results demonstrate that a troponin extension, likely to involve TnT and/or parts of the troponin core domain complex, promotes tropomyosin movement away from the blocking position and stabilizes it in the C-state position. Our work therefore supports the view that troponin exhibits dual function, inhibiting actin-myosin interaction at low Ca
2+ and facilitating interaction at high Ca
2+. Our results suggest further that troponin transforms tropomyosin’s fundamentally ambiguous position on striated muscle actin by dampening tropomyosin’s oscillatory behavior, while actively promoting its movement to B- or C-state configurations.